Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDRT15 pseudogene 13 (CDRT15P13) is classified as a pseudogene—typically defined as a segment of DNA that resembles a functional gene but has lost its protein-coding ability due to mutations or deletions. Pseudogenes may arise from gene duplications, retrotransposition events, or accumulated mutations that prevent synthesis of active proteins[1][6][10]. CDRT15P13 is related to CDRT15 (CMT1A Duplicated Region Transcript 15), a protein-coding gene on chromosome 17, but unlike its parental gene, CDRT15P13 does not produce functional protein and is not involved in any known therapeutic mechanism or disease association. Pseudogenes like CDRT15P13 may occasionally play regulatory roles at the RNA level in gene networks but there is currently no evidence of such activity or clinical relevance for this locus[1][6][7].
None (no drugs target the RNA or gene locus of CDRT15P13)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDRT15 pseudogene 13 (CDRT15P13).